See related: Company Information | News & Comment

Anxiety Disorders Market Forecast
Full analysis of the current and future anxiety disorders drug market, with indication-specific sales value and volume forecasts to 2017 of branded, generic, and key pipeline drugs in the US, Japan, and five major European markets.

Molecular Diagnostics: a primer on an emerging sector
This report assesses the molecular diagnostics (MDx) market. The current MDx market size and leading players are analyzed, with a market forecast of the MDx segment as well as the total in vitro diagnostic (IVD) market from 2007-13 also provided

Pipeline and Commercial Insight: Anxiety Disorders - Viable indication for antipsychotics companies
Full analysis of the current and future anxiety disorders drug market, with indication-specific sales value and volume forecasts to 2017 of branded, generic, and key pipeline drugs in the US, Japan, and five major European markets.

Stakeholder Opinions: Restless Legs Syndrome - Novel drugs to prosper as lifecycle management strategies fail
Full analysis of the current restless legs syndrome (RLS) market, with indication-specific value and volume product sales between 2004-07 in the US, Japan, and five major European markets as well as an assessment of key pipeline drugs.

Stakeholder Insight: Systemic Lupus Erythematosus Imprecise segmentation complicates treatment algorithms
Overview of current treatment trends for lupus based upon interviews with 180 rheumatologists in the US, Japan, France, Germany, Italy, Spain and the UK; supported by comments from international opinion leaders.

Stakeholder Opinions: Bladder Cancer - New drugs needed to challenge ineffective 20-year old drugs

Shire plc: PharmaVitae Profile

Menarini: PharmaVitae Profile

Pipeline Insight: Orphan Diseases in Neurology - Part III: Myasthenia Gravis

Stakeholder Opinions: Diabetic Renal Disease

RNA therapy: the next big thing after monoclonal antibodies?

Sepracor Inc.: PharmaVitae Profile

Commercial Insight: Pain Market Overview - Non-traditional analgesics and opioid reformulations to sustain sector growth

Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth

Pipeline Insight: Non-Insulin Antidiabetics - Incretin mimetics, leaders in a diverse pipeline

Hypertension Market Forecast

M&A trends in Pharma: Takeover activity in the last two and a half years

Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth

Biogen Idec Inc.: PharmaVitae Profile

Solvay S.A.: PharmaVitae Profile

Emerging Markets Series: The Pharmaceutical Market of South Korea

Les Laboratoires Servier: PharmaVitae Profile

Merck KGaA: PharmaVitae Profile

Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value

Schizophrenia Market Forecast